Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05570188Phase 1/2Withdrawn
Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies
B-cell LeukemiaB-cell Lymphoma
PrincipalinvestigatorStart date: 2022-10-01
NCT05571540Phase 1/2Withdrawn
Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
B-ALLB-cell Acute Lymphoblastic Leukemia
PrincipalinvestigatorStart date: 2022-10-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Kunming Hope of Health Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05570188Phase 1/2PrincipalInvestigator

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

B-cell LeukemiaB-cell Lymphoma
Withdrawn
NCT05571540Phase 1/2PrincipalInvestigator

Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL

B-ALLB-cell Acute Lymphoblastic Leukemia
Withdrawn

All 2 trials loaded